Skip to main content

Day: October 23, 2024

Influenza Diagnostics Market is Poised to Register CAGR of 3.5% by 2031 | SkyQuest Technology

Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031). Westford, USA, Oct. 23, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031). Advancements in molecular and biomedical technology have presented many tools and assays helpful in the detection and treatment of influenza infections. New technologies based on proteomics, such as microarray detection, and genomics, such as PCR, make it easier to develop new influenza viruses. In addition, they give the diagnostics market a chance for influenza diagnostics through them as they allow improved surveillance and faster detection of viral disorders. Furthermore, due to the...

Continue reading

Micron SSDs Qualified for Recommended Vendor List on NVIDIA GB200 NVL72

Micron 9550 PCIe Gen5 data center SSD delivers high-performance, energy-efficient storage for GB200 NVL72 systems BOISE, Idaho, Oct. 23, 2024 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today announced that its 9550 PCIe Gen5 E1.S data center SSDs have been added to the NVIDIA recommended vendor list (RVL) for the NVIDIA GB200 NVL72 system and its derivatives. The GB200 NVL72 uses the GB200 Grace Blackwell Superchip to deliver rack-scale, energy-efficient AI infrastructure. The enablement of PCIe Gen5 storage in the system makes the Micron 9550 SSD an ideal fit for optimizing performance and power efficiency in AI workloads like large-scale training of AI models, real-time trillion-parameter language model inference and high-performance computing (HPC) tasks. Micron 9550 delivers world-class AI workload performance...

Continue reading

LEARN selects Nokia to deploy new high-capacity network to foster research and education in Texas

Press ReleaseLEARN selects Nokia to deploy new high-capacity network to foster research and education in TexasMulti-year agreement sets Nokia as a key collaborator for LEARN’s high-capacity IP/MPLS network to meet growing capacity demands supporting research and education purposes. Enables high-speed access to foster scientific discovery and pedagogical developments in the state. Nokia industry-leading IP routing technology delivers 400G interfaces today with ability to seamlessly upgrade to 800G in the future.  23 October 2024 Dallas, Texas – Nokia today announced its collaboration with The Lonestar Education and Research Network (LEARN), the statewide Research and Education Network for the state of Texas, to upgrade LEARN’s existing packet platform. The collaboration is part of LEARN’s strategic NextGen Network initiative, which...

Continue reading

Wealth Management Market is Poised to Register CAGR of 13.9% by 2031 | SkyQuest Technology

Westford,USA, Oct. 23, 2024 (GLOBE NEWSWIRE) — Wealth Management Market size was valued at USD 3.75 billion in 2022 and is poised to grow from USD 4.27 billion in 2023 to USD 12.07 billion by 2031, growing at a CAGR of 13.9% in the forecast period (2024-2031). The demand for alternative assets such as hedge funds, commodities, private equity, REITS, and intellectual property has been increasing, and this is one of the major drivers for the global wealth management business. On the other hand, emergence of FinTechs or financial technology has hindered the wealth management business. The key benefits of wealth management include the creation of financial plans and the lessening of financial stress, and with the general acceptance of digitalized products within the industry, this tends to drive growth in the market. The market is...

Continue reading

Unifirst Announces Financial Results for the Fourth Quarter and Full Fiscal Year of Fiscal 2024

WILMINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its fourth quarter and full year ended August 31, 2024, as compared to the corresponding periods in the prior fiscal year. The fourth quarter as well as the full year included an extra week compared to the prior year. Q4 2024 Financial HighlightsConsolidated revenues for the fourth quarter increased 11.9% to $639.9 million. The extra week accounted for revenue growth of approximately 8.0% in the quarter. Operating income was $54.0 million, an increase of 49.8%. The quarterly tax rate decreased to 21.8% compared to 24.3% in the prior year. Net income increased to $44.6 million, or 61.5%. Diluted earnings per share increased to $2.39 from $1.47 in the prior year, or 62.6%. Adjusted...

Continue reading

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 2,050,000 shares of the Company’s common stock at a price of $1.00 per share of common stock in a registered direct offering. In addition, in a concurrent private placement, the Company will issue to the investors series E warrants to purchase up to 2,050,000 shares of common stock and series F warrants to purchase up to 2,050,000 shares of common stock. The series E warrants have an exercise price of $1.13 per share, will be exercisable six months following the date...

Continue reading

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting

SOLANA BEACH, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti® (metoclopramide) nasal spray, announced upcoming poster presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Philadelphia, held from October 25-29, 2024. Evoke will feature two poster presentations highlighting the use of Gimoti® (metoclopramide) nasal spray in patients. Notably, one of these abstracts, Poster P3339, has been honored with the prestigious ACG’s Outstanding Research Award in the Stomach Category for the top abstract across this section of research. It has also been awarded the Presidential Poster Award—a distinction granted to fewer than 5% of submitted abstracts...

Continue reading

One Stop Systems to Report Third Quarter 2024 Financial Results

Conference Call to be Held Wednesday, November 6, 2024, at 10:00 a.m. ET ESCONDIDO, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, announced today that the Company will release its third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024. A webcast and conference call will be held that same day at 10:00 a.m. ET to review the Company’s results. Conference Call and Webcast Domestic: 1-800-717-1738International: 1-646-307-1865Conference ID: 13748 (required for entry)Webcast:  https://viavid.webcasts.com/starthere.jsp?ei=1692609&tp_key=bc360380ca Conference Call Replay Domestic: 1-844-512-2921International:...

Continue reading

BBSI Sets Third Quarter 2024 Conference Call for Wednesday, November 6, 2024, at 5:00 p.m. ET

VANCOUVER, Washington, Oct. 23, 2024 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions, will conduct a conference call on Wednesday, November 6, 2024, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the third quarter ended September 30, 2024. The company will report its financial results in a press release prior to the conference call. BBSI’s CEO Gary Kramer and CFO Anthony Harris will host the conference call, followed by a question and answer period. Date: Wednesday, November 6, 2024Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)Toll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID: 13748631 Please call the conference telephone number 5-10 minutes prior to the start...

Continue reading

Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, November 6, 2024, to discuss its financial and operating results for the third quarter of 2024. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time. A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days. About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.